Joanna Liss's research while affiliated with University of Gdansk and other places

What is this page?

This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)

Comparison of s-SCF levels between study groups. Violin plots depict summary statistics and the density of each variable; they were not correlated with any of the clinical variables. The table below describes the mean s-SCF value (pg/ml) ± standard deviation (in parentheses) during controlled ovarian hyperstimulation. No significant differences in s-SCF levels were observed between the subgroups (Mann–Whitney U test, p > 0.05). DOR, diminished ovarian reserve; DS, day of stimulation; NOR, normal ovarian reserve; PCOS, polycystic ovary syndrome; s-SCF, serum stem cell factor; * day of oocyte retrieval (pick-up).
Comparison of s-SCF levels (pg/ml) between the study groups in relation to blastocyst quality. s-SCF levels were measured on the 1st day (A) and 8th day (B) of stimulation and on the oocyte retrieval day (C) in the studied groups. Patients within the groups were divided into subgroups depending on whether TQ blastocyt was obtained (true) or not (false). Box plots represent the distribution of variables. Means are marked with red points. Statistical significance was determined using the Mann–Whitney U test with p-value < 0.05 considered significant. DOR, diminished ovarian reserve; NOR, normal ovarian reserve; PCOS, polycystic ovary syndrome; s-SCF, serum stem cell factor; TQ, top-quality.
Serum levels of stem cell factor for predicting embryo quality
  • Article
  • Full-text available

May 2024

·

15 Reads

Scientific Reports

Joanna Liss

·

Martyna Kuczyńska

·

Michał Kunicki

·

[...]

·

We evaluated whether serum stem cell factor (s-SCF) levels just prior to ovulation induction could indicate the ability to develop a top-quality (TQ) blastocyst by day 5. We investigated patients with normal ovarian reserve (NOR), polycystic ovary syndrome (PCOS), diminished ovarian reserve (DOR), or mild endometriosis. Our pilot research suggests a correlation between s-SCF levels and the ability to form TQ blastocysts in patients with mild endometriosis. This significant statistical difference (p < 0.05) was noted between mild endometriosis patients for whom a TQ blastocyst was obtained and those for whom it was not possible, as measured on the 8th day of stimulation and the day of oocyte retrieval. The mean SCF levels in the serum of these women on the 8th day were at 28.07 (± 2.67) pg/ml for the TQ subgroup and 53.32 (± 16.02) pg/ml for the non-TQ subgroup (p < 0.05). On oocyte retrieval day it was 33.47 (± 3.93) pg/ml and 52.23 (± 9.72) pg/ml (p < 0.05), respectively.

Download
Share